纳米材料诱导的金属离子干扰疗法在癌症治疗中:从瘤微环境重编程到细胞命运调节
Xinyu Liu1, Yucui Ding1, Jianlong Fu1
1School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Basic Science Research Center Base (Pharmaceutical Science), Yantai University, Yantai 264005, China.
Colloids and surfaces. B, Biointerfaces
|February 28, 2026
概括
金属离子干扰疗法 (MIIT) 使用必需的金属离子来破坏癌细胞平衡,诱导细胞死亡以增强抗瘤作用. 需要进一步的研究来优化组合疗法,并克服有效癌症治疗的翻译挑战.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
背景情况:
- 金属离子干扰疗法 (MIIT) 利用必需的离子 (Ca2+,Fe2+,Cu2+,Mn2+,Zn2+) 来调节癌细胞的命运.
- MIIT 破坏细胞内离子稳态,影响瘤的微环境,并诱导受计划的细胞死亡 (亡,铁亡,亡,热亡).
研究的目的:
- 系统地审查MIIT在癌症治疗中的机制和协同战略.
- 探索MIIT在调节氧化还原平衡,缓解瘤缺氧和破坏新陈代谢途径方面的应用.
- 讨论MIIT与其他疗法的协同作用潜力,并评估转化障碍.
主要方法:
- 对金属离子干扰疗法的现有文献进行系统审查.
- 分析MIIT对细胞代谢,氧化还原平衡和瘤微环境的影响.
- 综合疗法和翻译挑战的评估.
主要成果:
- MIIT有效地诱导各种形式的编程细胞死亡,并增强抗瘤功效.
- 在向电子运输链 (ETC) 方面,MIIT显示出潜在的潜力,以损害瘤生物能.
- 涉及MIIT与免疫疗法和其他方式的协同战略是有希望的.
结论:
- MIIT是一种具有重大潜力的创新癌症治疗方法.
- 需要进一步的研究,以了解复杂的离子细胞相互作用,并优化组合疗法.
- 解决毒性和狭窄的治疗窗口等转化障碍对于临床应用至关重要.
相关概念视频
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K


